Pillstats
Rx only · Tablet, Extended Release · Oral

Guanfacine

Brands: Intuniv · Guanfacine Hydrochloride

18 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US83 NDCs
18 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATC—
RxCUI (US)—
US makers18 labelers
Packages137
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 39 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.340$0.681$1.02$1.36Dec 2025Mar 2026Jun 2026
$1.110
Latest avg · Jun 17, 2026
-6%
Since Dec 17, 2025
18
Active US suppliers
26%
Top-2 supplier share*

Who makes it18 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Proficient Rx LPunknown20SUPPLYING
Advagen Pharma Ltdunknown16SUPPLYING
Alembic Pharmaceuticals Limitedunknown16SUPPLYING
Bryant Ranch Prepackrepackager12SUPPLYING
Upsher-Smith Laboratories, LLCunknown12SUPPLYING
SUN PHARMACEUTICAL INDUSTRIES, INC.unknown11SUPPLYING
Golden State Medical Supply, Inc.unknown8SUPPLYING
REMEDYREPACK INC.repackager6SUPPLYING
Actavis Pharma, Inc.unknown4SUPPLYING
Takeda Pharmaceuticals America, Inc.unknown4SUPPLYING
NorthStar RxLLCunknown4SUPPLYING
Unichem Pharmaceuticals (USA), Inc.unknown4SUPPLYING
Fosun Pharma USA Incunknown4SUPPLYING
Slate Run Pharmaceuticals, LLCunknown4SUPPLYING
AvKAREunknown4SUPPLYING

+ 3 more labelers

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.